Journal article Open Access


Gharmalkar Samruddhi .K*, Prof. A.L. Ware

Ofloxacin is one of a new generation of fluorinated quinolones structurally related to nalidixic acid. It is orally administrated broad spectrum anti-bacterial & some anaerobes. Moreover ofloxacin achieves high concentration in most tissues and body fluids. The result of clinical trials with ofloxacin have confirmed the potential for use in a wide range of infections, which was indicated by its in vitro anti-bacterial & pharmacokinetics profiles. It has proven effective against a high percentage of infection caused by gram-negative organisms, slightly less effective against gram positive infections, & effective against some anaerobic infections. Ofloxacin is well tolerated & although experience with the drug in clinical practices to date is limited, bacterial resistance does not appear to develop readily. Thus, ofloxacin is an orally active drug which offers a valuable alternative to other broad spectrum anti-bacterial drug. The synythesis of Ofloxacin was carried out in this article. And quinoline-4(1H)-one is the intermediate that was found in this Ofloxacin. There physiochemical properties & characterization of impurity is also described.

Files (1.3 MB)
Name Size
1.3 MB Download
All versions This version
Views 2626
Downloads 1313
Data volume 16.7 MB16.7 MB
Unique views 2525
Unique downloads 1313


Cite as